PBPK, QSP & biosimulationconfirmed

Certara

Largest model-informed drug development vendor: Simcyp PBPK simulator, QSP and cheminformatics.

Notable

Simcyp became the first PBPK platform with an EMA qualification opinion (Aug 2025). Bought Applied BioMath (2023) and Chemaxon (2024); selling its writing unit to Veristat (2026).

Related deals

Apr 22, 2026
Divestiture
Certara is selling its regulatory and medical writing unit ($50M of 2025 revenue) to focus on model-informed drug development.
up to $135M
ir.certara.com(opens in new tab)

Related updates

No related news yet.